SCHEMBL5274385

SCHEMBL5274385

COCCC1CC(NC(=O)OC(C)(C)C)CCC1NC(=O)OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CPB1 P15086 2/20 0.50
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
KMT2A Q03164 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
TSHR P16473 1/20 0.47
KDM1A O60341 2/20 0.46
MAOB P27338 2/20 0.46
CCR2 P41597 1/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
ACHE P22303 2/20 0.44
TLR4 O00206 1/20 0.43
EPHX1 P07099 1/20 0.42
PDE4B Q07343 1/20 0.41
DRD2 P14416 1/20 0.41
SYK P43405 1/20 0.41
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
CTSK P43235 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3746716 1.00 CPB1 (0.50) CPB1ALDH1A1GAAKMT2AL3MBTL1
SCHEMBL5274381 1.00 CPB1 (0.50) CPB1ALDH1A1GAAKMT2AL3MBTL1
SCHEMBL5259011 0.90 ALDH1A1 (0.50) CPB1ALDH1A1GAAKMT2AL3MBTL1
SCHEMBL3736730 0.90 CPB1 (0.52) CPB1ALDH1A1GAAKMT2AL3MBTL1
SCHEMBL3736732 0.90 CPB1 (0.52) CPB1ALDH1A1GAAKMT2AL3MBTL1
SCHEMBL27647240 0.90 CPB1 (0.52) CPB1ALDH1A1GAAKMT2AL3MBTL1
SCHEMBL3733016 0.90 ALDH1A1 (0.50) CPB1ALDH1A1GAAKMT2AL3MBTL1
SCHEMBL5259014 0.90 ALDH1A1 (0.50) CPB1ALDH1A1GAAKMT2AL3MBTL1
SCHEMBL3733860 0.88 ALDH1A1 (0.52) CPB1ALDH1A1GAAKMT2AL3MBTL1
SCHEMBL5027125 0.88 ALDH1A1 (0.52) CPB1ALDH1A1GAAKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1656138-A4 SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL MYERS SQUIBB CO (US) 2007-04-18 EP disclosed
EP-1656138-A2 SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Company (US) 2006-05-17 EP disclosed
WO-2005020899-A2 SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2005-03-10 WO disclosed